Potential Role of Xylitol Plus Grapefruit Seed Extract Nasal Spray Solution in COVID-19: Case Series
Camille Celeste Go, Krunal Pandav, Marcos A Sanchez-Gonzalez, Gustavo Ferrer
Cureus, doi:10.7759/cureus.11315
The SARS-CoV-2 virus has created an unprecedented impact on healthcare globally. Being a novel virus, several treatments have been explored against COVID-19. During the early stages of the disease, treatment is mainly supportive. While several studies have suggested different treatment modalities, there is still no definitive treatment against COVID-19. Re-purposing already established medications, with excellent safety profiles, is a possible approach for treating the disease in its early stage. Having a mode of transmission as a droplet mode, several studies have supported how the nose can contain the primary route of entry of SARS-CoV-2. Hence, we postulated that re-purposing a commercially available nasal spray containing xylitol and grapefruit seed extract (GSE), namely Xlear Nasal Spray® (Xlear, Inc., American Fork, USA) could be used as an adjunct treatment of COVID-19. With a well-established safety profile, the components of this nasal spray have been studied and have been shown to have potential efficacy against viral pathogens, including coronavirus, and may potentially regulate pathways important in the initial entry of infection, replication, and systemic response to SARS-CoV-2. We present a series of three mild-moderate risks, symptomatic, COVID-19 patients, treated with the intranasal combination, as an adjuvant to their ongoing treatment, with rapid clinical improvement and shorten time to negativization on repeat intranasal swab test via PCR. No safety issues were noted during the course of treatment. Xlear nasal spray, containing xylitol plus GSE, given its established safety profile and compelling clinical results described here, could be a potential adjunct treatment option in mild-moderate COVID-19 cases.
Additional Information Disclosures
References
Bitter, Suter-Zimmermann, Surber, Nasal drug delivery in humans, Curr Probl Dermatol,
doi:10.1159/000321044Garcia, Schroeter, Segal, Stanek, Foureman et al., Dosimetry of nasal uptake of watersoluble and reactive gases: a first study of interhuman variability, Inhal Toxicol,
doi:10.1080/08958370802320186Gengler, Wang, Speth, Sedaghat, Sinonasal pathophysiology of SARS-CoV-2 and COVID-19: a systematic review of the current evidence, Laryngoscope Investig Otolaryngol,
doi:10.1002/lio2.384Helassa, Garnett, Farrant, A novel fluorescent sensor protein for detecting changes in airway surface liquid glucose concentration, Biochem J,
doi:10.1042/BJ20141041Jia, Look, Shi, ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia, J Virol,
doi:10.1128/JVI.79.23.14614-14621.2005Komura, Suzuki, Sangsriratanakul, Inhibitory effect of grapefruit seed extract (GSE) on avian pathogens, J Vet Med Sci,
doi:10.1292/jvms.18-0754Pires, Fortuna, Alves, Falcão, Intranasal drug delivery: how, why and what for?, J Pharm Pharm Sci,
doi:10.18433/j3nc79Sungnak, Huang, Bécavin, SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes, Nat Med,
doi:10.1038/s41591-020-0868-6DOI record:
{
"DOI": "10.7759/cureus.11315",
"ISSN": [
"2168-8184"
],
"URL": "http://dx.doi.org/10.7759/cureus.11315",
"author": [
{
"affiliation": [],
"family": "Go",
"given": "Camille Celeste",
"sequence": "first"
},
{
"affiliation": [],
"family": "Pandav",
"given": "Krunal",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Sanchez-Gonzalez",
"given": "Marcos A",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Ferrer",
"given": "Gustavo",
"sequence": "additional"
}
],
"container-title": "Cureus",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2020,
11,
3
]
],
"date-time": "2020-11-03T19:37:54Z",
"timestamp": 1604432274000
},
"deposited": {
"date-parts": [
[
2020,
11,
3
]
],
"date-time": "2020-11-03T19:38:00Z",
"timestamp": 1604432280000
},
"indexed": {
"date-parts": [
[
2023,
10,
27
]
],
"date-time": "2023-10-27T15:19:21Z",
"timestamp": 1698419961111
},
"is-referenced-by-count": 13,
"issued": {
"date-parts": [
[
2020,
11,
3
]
]
},
"language": "en",
"link": [
{
"URL": "https://www.cureus.com/articles/43909-potential-role-of-xylitol-plus-grapefruit-seed-extract-nasal-spray-solution-in-covid-19-case-series",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "4492",
"original-title": [],
"prefix": "10.7759",
"published": {
"date-parts": [
[
2020,
11,
3
]
]
},
"published-print": {
"date-parts": [
[
2020,
11,
3
]
]
},
"publisher": "Cureus, Inc.",
"reference": [
{
"key": "ref1",
"unstructured": "People with certain medical conditions. (2020). Accessed. October 6, 2020: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html."
},
{
"key": "ref2",
"unstructured": "COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). (2020). Accessed. October 6, 2020: https://coronavirus.jhu.edu/map.html."
},
{
"DOI": "10.1038/s41591-020-0868-6",
"article-title": "SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes",
"author": "Sungnak W",
"doi-asserted-by": "publisher",
"journal-title": "Nat Med",
"key": "ref3",
"unstructured": "Sungnak W, Huang N, Bécavin C, et al.. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020, 26:681-687. 10.1038/s41591-020-0868-6",
"volume": "26",
"year": "2020"
},
{
"DOI": "10.1002/lio2.384",
"article-title": "Sinonasal pathophysiology of SARS-CoV-2 and COVID- 19: a systematic review of the current evidence",
"author": "Gengler I",
"doi-asserted-by": "publisher",
"journal-title": "Laryngoscope Investig Otolaryngol",
"key": "ref4",
"unstructured": "Gengler I, Wang JC, Speth MM, Sedaghat AR. Sinonasal pathophysiology of SARS-CoV-2 and COVID- 19: a systematic review of the current evidence. Laryngoscope Investig Otolaryngol. 2020, 16:354-359. 10.1002/lio2.384",
"volume": "16",
"year": "2020"
},
{
"key": "ref5",
"unstructured": "Iota-carrageenan and Xylitol inhibit SARS-CoV-2 in cell culture. (2020). Accessed. October 6, 2020: https://www.biorxiv.org/content/10.1101/2020.08.19.225854v1."
},
{
"DOI": "10.1292/jvms.18-0754",
"article-title": "Inhibitory effect of grapefruit seed extract (GSE) on avian pathogens",
"author": "Komura M",
"doi-asserted-by": "publisher",
"journal-title": "J Vet Med Sci",
"key": "ref6",
"unstructured": "Komura M, Suzuki M, Sangsriratanakul N, et al.. Inhibitory effect of grapefruit seed extract (GSE) on avian pathogens. J Vet Med Sci. 2019, 81:466-472. 10.1292/jvms.18-0754",
"volume": "81",
"year": "2019"
},
{
"DOI": "10.1001/jama.2020.8391",
"article-title": "Olfactory Dysfunction in COVID- 19: diagnosis and Management",
"author": "Whitcroft KL",
"doi-asserted-by": "publisher",
"journal-title": "JAMA",
"key": "ref7",
"unstructured": "Whitcroft KL, Hummel T. Olfactory Dysfunction in COVID- 19: diagnosis and Management. JAMA. 2020, 323:2512-2514. 10.1001/jama.2020.8391",
"volume": "323",
"year": "2020"
},
{
"DOI": "10.1016/j.transci.2020.102926",
"article-title": "Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection [PREPRINT]",
"author": "Hariyanto TI",
"doi-asserted-by": "publisher",
"journal-title": "Transfus Apher Sci",
"key": "ref8",
"unstructured": "Hariyanto TI, Kurniawan A. Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection [PREPRINT]. Transfus Apher Sci. 2020, 102926. 10.1016/j.transci.2020.102926",
"year": "2020"
},
{
"DOI": "10.1159/000321044",
"article-title": "Nasal drug delivery in humans",
"author": "Bitter C",
"doi-asserted-by": "publisher",
"journal-title": "Curr Probl Dermatol",
"key": "ref9",
"unstructured": "Bitter C, Suter-Zimmermann K, Surber C. Nasal drug delivery in humans. Curr Probl Dermatol. 2011, 40:20-35. 10.1159/000321044",
"volume": "40",
"year": "2011"
},
{
"DOI": "10.1080/08958370802320186",
"article-title": "Dosimetry of nasal uptake of water-soluble and reactive gases: a first study of interhuman variability",
"author": "Garcia GJ",
"doi-asserted-by": "publisher",
"journal-title": "Inhal Toxicol",
"key": "ref10",
"unstructured": "Garcia GJ, Schroeter JD, Segal RA, Stanek J, Foureman GL, Kimbell JS. Dosimetry of nasal uptake of water-soluble and reactive gases: a first study of interhuman variability. Inhal Toxicol. 2009, 21:607-618. 10.1080/08958370802320186",
"volume": "21",
"year": "2009"
},
{
"DOI": "10.2174/156720112803529828",
"article-title": "Anatomical and histological factors affecting intranasal drug and vaccine delivery",
"author": "Gizurarson S",
"doi-asserted-by": "publisher",
"journal-title": "Current Drug Delivery",
"key": "ref11",
"unstructured": "Gizurarson S. Anatomical and histological factors affecting intranasal drug and vaccine delivery. Current Drug Delivery. 2012, 9:566-582. 10.2174/156720112803529828",
"volume": "9",
"year": "2012"
},
{
"DOI": "10.18433/j3nc79",
"article-title": "Intranasal drug delivery: how, why and what for?",
"author": "Pires A",
"doi-asserted-by": "publisher",
"journal-title": "J Pharm Pharm Sci",
"key": "ref12",
"unstructured": "Pires A, Fortuna A, Alves G, Falcão A. Intranasal drug delivery: how, why and what for?. J Pharm Pharm Sci. 2009, 12:288-311. 10.18433/j3nc79",
"volume": "12",
"year": "2009"
},
{
"DOI": "10.1042/BJ20141041",
"article-title": "A novel fluorescent sensor protein for detecting changes in airway surface liquid glucose concentration",
"author": "Helassa N",
"doi-asserted-by": "publisher",
"journal-title": "Biochem J",
"key": "ref13",
"unstructured": "Helassa N, Garnett JP, Farrant M, et al.. A novel fluorescent sensor protein for detecting changes in airway surface liquid glucose concentration. Biochem J. 2014, 464:213-220. 10.1042/BJ20141041",
"volume": "464",
"year": "2014"
},
{
"DOI": "10.1016/0091-6749(92)90161-t",
"article-title": "Anatomic and physiologic considerations in sinusitis",
"author": "Wagenmann M",
"doi-asserted-by": "publisher",
"journal-title": "J Allergy Clin Immunol",
"key": "ref14",
"unstructured": "Wagenmann M, Naclerio RM. Anatomic and physiologic considerations in sinusitis. J Allergy Clin Immunol. 1992, 90:419-423. 10.1016/0091-6749(92)90161-t",
"volume": "90",
"year": "1992"
},
{
"DOI": "10.1016/j.cell.2020.05.042",
"article-title": "SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract",
"author": "Hou YJ",
"doi-asserted-by": "publisher",
"journal-title": "Cell",
"key": "ref15",
"unstructured": "Hou YJ, Okuda K, Edwards CE, et al.. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell. 2020, 182:429-446. 10.1016/j.cell.2020.05.042",
"volume": "182",
"year": "2020"
},
{
"DOI": "10.1128/JVI.79.23.14614-14621.2005",
"article-title": "ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia",
"author": "Jia HP",
"doi-asserted-by": "publisher",
"journal-title": "J Virol",
"key": "ref16",
"unstructured": "Jia HP, Look DC, Shi L, et al.. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005, 79:14614-14621. 10.1128/JVI.79.23.14614-14621.2005",
"volume": "79",
"year": "2005"
},
{
"key": "ref17",
"unstructured": "Researchers map how coronavirus infection travels through cells of nasal cavity and respiratory tract. (2020). Accessed. October 8, 2020: https://www.unc.edu/posts/2020/06/08/researchers-map-how-coronavirus-infection-travels-through-cells-of-nasal-cavity-...."
},
{
"DOI": "10.3346/jkms.2020.35.e174",
"article-title": "Prevalence and duration of acute loss of smell or taste in COVID-19 patients",
"author": "Lee Y",
"doi-asserted-by": "publisher",
"journal-title": "J Korean Med Sci",
"key": "ref18",
"unstructured": "Lee Y, Min P, Lee S, Kim SW. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020, 35:e174. 10.3346/jkms.2020.35.e174",
"volume": "35",
"year": "2020"
}
],
"reference-count": 18,
"references-count": 18,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.cureus.com/articles/43909-potential-role-of-xylitol-plus-grapefruit-seed-extract-nasal-spray-solution-in-covid-19-case-series"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Aerospace Engineering"
],
"subtitle": [],
"title": "Potential Role of Xylitol Plus Grapefruit Seed Extract Nasal Spray Solution in COVID-19: Case Series",
"type": "journal-article"
}
